NRPR Stock Overview

Engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. More details

NRPR fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($20K)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Nutri Pharmaceuticals Research, Inc. Competitors

LifeQuest World

OTCPK:LQWC

US$1.3m

Nevis Brands

OTCPK:NEVI.F

US$2.1m

Shineco

NasdaqCM:SISI

US$21.6m

Cyanotech

OTCPK:CYAN

US$2.6m

Price History & Performance

Summary of share price highs, lows and changes for Nutri Pharmaceuticals Research
Historical stock prices
Current Share Price	US$0.021
52 Week High	US$0.022
52 Week Low	US$0.0072
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	31.25%
3 Year Change	-47.50%
5 Year Change	247.11%
Change since IPO	-96.50%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NRPR	US Personal Products	US Market
7D	0%	2.3%	1.2%
1Y	31.3%	-28.1%	23.7%

Return vs Industry: NRPR exceeded the US Personal Products industry which returned -28.1% over the past year.

Return vs Market: NRPR exceeded the US Market which returned 23.7% over the past year.

Price Volatility

Is NRPR's price volatile compared to industry and market?
NRPR volatility
NRPR Average Weekly Movement	n/a
Personal Products Industry Average Movement	7.8%
Market Average Movement	5.9%
10% most volatile stocks in US Market	18.0%
10% least volatile stocks in US Market	3.0%

Stable Share Price: NRPR's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine NRPR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	Godfrey Yew	www.o2pus.com

Nutri Pharmaceuticals Research, Inc. engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company uses its ‘oil to powder’ products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and organic household products.

Nutri Pharmaceuticals Research, Inc. Fundamentals Summary

How do Nutri Pharmaceuticals Research's earnings and revenue compare to its market cap?
NRPR fundamental statistics
Market cap	US$19.71k
Earnings (TTM)	-US$467.59k
Revenue (TTM)	US$1.21m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is NRPR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NRPR income statement (TTM)
Revenue	US$1.21m
Cost of Revenue	US$701.63k
Gross Profit	US$509.58k
Other Expenses	US$977.17k
Earnings	-US$467.59k

Last Reported Earnings

Sep 30, 2004

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did NRPR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 22:28
End of Day Share Price	2025/01/31 00:00
Earnings	2004/09/30
Annual Earnings	2003/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nutri Pharmaceuticals Research, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.